Diverticulosis, Colonic Clinical Trial
Official title:
A Pilot/Phase 1, Interventional, Open-label, Multi-center Study to Assess the Safety and Efficacy of L-glutamine Treatment in Patients With Diverticulosis
The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.
After being informed about the study and potential risks, all patients giving written informed consent will undergo a 4 weeks screening period to determine eligibility for study entry. At Week 0, patients who meet eligibility requirements will be given L-glutamine (15 grams, twice daily) ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03602677 -
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
|
N/A | |
Completed |
NCT00535652 -
Concentration of Ertapenem in Colorectal Tissue
|
Phase 4 | |
Not yet recruiting |
NCT03465293 -
Influence of Mechanical Bowel Preparation on GI Microbiota
|
N/A | |
Completed |
NCT03619538 -
Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery
|
N/A | |
Recruiting |
NCT04279821 -
Prevalence of Segmental Colitis Associated With Colic Diverticulosis (SCAD)
|
||
Recruiting |
NCT02752360 -
Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis
|
Phase 1 | |
Completed |
NCT00663247 -
Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease
|
N/A | |
Completed |
NCT05384925 -
Prior Abdominal Surgery: A Potential Risk Factor for Colonic Diverticulosis or Diverticulitis
|